Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

© Shutterstock

Associate Professor Simon Rinaldi has received funding from the University of Oxford’s COVID-19 Research Response Fund to investigate this further. He and colleagues will compare the prevalence of SARS-CoV-2 polymerase chain reaction and seropositivity in a UK cohort of GBS patients identified during the pandemic, and compare GBS incidence rates to similar periods in previous years.

This will establish how often COVID-19 is complicated by GBS. By characterising COVID-GBS associated antibody and cytokine profiles, and evaluating their pathological effects in a myelinating culture model, the team will learn more about the underlying neuroimmunology of this disorder. 

Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

Newborn brain scans clarify how some diseases develop

Newborn brain scans from the Developing Human Connectome Project are now available online in large-scale open-source project, clarifying how some diseases develop.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.